Skip to main content
. 2022 Oct 25;12:17856. doi: 10.1038/s41598-022-22507-3

Figure 2.

Figure 2

HTR-8 cell migration is regulated by ligands targeting CRY1/2 and NR1D1/2. Wound healing assays in HTR-8 cells, show that (A, B) KL001, a drug stabilizing CRY1/2, but not KL101, a drug stabilizing CRY1, reduced HTR-8 cell migration. (C, D) PF670462, a drug preventing PER1/2/3 degradation, did not impact HTR-8 cell migration. (EG) The NR1D1/2 agonist SR9009, had no significant effect on migration, whereas the NR1D1/2 antagonist/inverse agonist, SR8278, decreased HTR-8 cell migration. All drugs were tested at 1 and 10 µM. The data were pooled if the two doses were not significantly different. (B, D, F, G) Illustrative wound healing assay images. Dotted line on histograms represents approximate wound area in control at 24 h. Data is expressed as % change in average wound size from 0 h ± SEM. N = 3–6, in duplicate. One-way ANOVA repeated measures, *, p < 0.05; ***, p < 0.001.